Clinical trials are carefully controlled research studies to determine the outcomes of using new medications and other treatments on human patients.
People who participate in clinical trials may be able to play a more active role in their own health care, gain access to new treatments before they are widely available, and help other patients by contributing to medical research.
But patients who are considering participating in a trial need to understand all the rules and procedures of the trial and the potential benefits and risk associated with it.
Clinical trials are playing a major role in the revolution in Hepatitis C treatment right now! To learn more about clinical trials and drugs being tested, attend this meeting and hear Tracy Swan speak:
The Midtown Manhattan Hepatitis C Support Group
(all are welcome - Hepatitis C patients, friends, family, all those interested in Hepatitis C)
Wednesday, July 27, 2011
560 First Avenue (between 30th and 31st Streets)
Main Entrance NYU Medical Center
Smilow Conference Romm 1301
(walk into the main entrance and ask security for directions)
Guest Speaker: Tracy Swan
Tracy Swan is the Hepatitis/HIV Project Director at the Treatment Action Group. Tracy has worked on HIV treatment issues since 1990 and on Hepatitis C issues since 1998. She focuses on promoting Hepatitis C research and policy initiatives that improve the quality of and access to care and treatment for patients. Tracy has written on the Hepatitis C drug pipeline and has a new book out on Hepatitis C clinical trials.
Tracy's topic on July 27 - Clinical trials and what to expect.